BackConmed Overview
Conmed Corp.

Conmed Target Price

Analysts' average 12-month price target for Conmed is $38.

Get informed when a big investor buys or sells

+ Follow

Share Price

$46.13

Average Target Price

$37.5018.7% downside

2 analysts in the last 4 months

High: $39 | Low: $36

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-13Wells Fargo$3915.5% downsideOpen
2026-07-08BMO Capital$3622% downsideOpen
2025-05-01NeedhamMike Matson$6132.2% upsideOpen
2024-10-04NeedhamMike Matson$97110.3% upsideOpen
2024-04-25Piper SandlerMatt O\'Brien$95105.9% upsideOpen
2024-04-25NeedhamMike Matson$107132% upsideOpen
2022-10-26Piper SandlerMatt O'Brien$108134.1% upsideOpen

Conmed (CNMD) FAQ

Conmed (CNMD) currently reports a target price of $38. Use the charts on this page to explore Conmed's target price history and peer comparisons.

Analysts' average 12-month price target for Conmed is $38, about 18.7% downside from the current share price of $46.13. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $38, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Conmed, and consider following CNMD for alerts when major investors trade the stock.

Conmed is classified in the Healthcare sector. On target price, it currently shows $38. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CNMD with unrelated industries.